The findings strongly suggest that neuroactive compounds of the KP may modify neuronal function and/or neurodevelopment in Ptchd1 KO mice, and further studies are required to investigate whether KP metabolites can be used as potential peripheral biomarkers for neurodevelopmental disorders. The gene discussed is PTCHD1; the disease is neurodevelopmental disorder.